ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

BHVN Biohaven Ltd

40.69
0.79 (1.98%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Biohaven Ltd BHVN NYSE 普通株式
  前日比 前日比 % 現在値 時刻
0.79 1.98% 40.69 09:00:00
始値 安値 高値 終値 前日終値
40.72 40.45 42.105 40.69 39.90
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2305:05PRNUSBiohaven Announces Closing of Public Offering and Full..
2024/4/1805:05PRNUSBiohaven Announces Proposed Public Offering of Common Shares
2024/4/1322:00PRNUSBiohaven Showcases Innovative Neuroscience Portfolio with 20..
2024/3/0106:16EDGAR2Form 8-K - Current report
2024/3/0106:05PRNUSBiohaven Reports Fourth Quarter and Full Year 2023 Financial..
2024/1/0821:30EDGAR2Form 8-K - Current report
2024/1/0821:30PRNUSBiohaven Highlights Progress Across Innovative Portfolio and..
2024/1/0221:00PRNUSBiohaven to Present at the 42nd Annual J.P. Morgan..
2023/12/0206:30PRNUSBiohaven Presents Expanded EEG and Safety Data for BHV-7000..
2023/11/1506:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1506:05PRNUSBiohaven Reports Third Quarter 2023 Financial Results and..
2023/10/1620:00PRNUSBiohaven Presents Preclinical Data Demonstrating..
2023/10/0605:05EDGAR2Form 8-K - Current report
2023/10/0605:05PRNUSBiohaven Announces Closing of Public Offering and Full..
2023/10/0505:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/0312:56PRNUSBiohaven Announces Pricing of $225 Million Public Offering..
2023/10/0310:41EDGAR2Form 8-K - Current report
2023/10/0306:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/0306:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/0305:36PRNUSBIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
2023/10/0305:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2023/9/2719:58EDGAR2Form 8-K - Current report
2023/9/1420:00PRNUSBiohaven Completes Enrollment in Pivotal Phase 3 Study of..
2023/9/0520:00PRNUSBiohaven Announces Positive Data from its Exploratory..
2023/8/0106:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0105:29EDGAR2Form 8-K - Current report
2023/7/3122:31PRNUSBiohaven's Taldefgrobep Alfa Receives EU Orphan Drug..
2023/7/3119:59PRNUSBiohaven Reports Second Quarter 2023 Financial Results and..
2023/7/2905:35EDGAR2Form 8-K - Current report
2023/7/2721:42DJNBiohaven Told That FDA Won't Review NDA Application for..
2023/7/2720:00PRNUSBiohaven Provides Preliminary EEG Data Update for Kv7..
2023/5/3120:00PRNUSBiohaven Provides Overview of Clinical Progress, Regulatory..
2023/5/2606:00PRNUSBiohaven to Present R&D Day at Yale School of Management
2023/5/1305:30PRNUSBiohaven Reports First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock